Calliditas Therapeutics AB announced that former Head of North America Commercial, Andrew Udell, has been promoted to President, North America, effective immediately. In his new role, Mr. Udell will oversee all of Calliditas' US related activities, with direct reports including sales, marketing and market access. Mr. Udell joined Calliditas in 2019 and has over 20 years of broad commercial experience in the pharmaceutical industry, working with both established and growing pharma companies.